Serum eotaxin-3 is a sensitive and specific marker for the diagnosis of active EGPA. SNPs in the eotaxin-3 gene do not predict the risk of developing EGPA. The gene discussed is CCL26; the disease is eosinophilic granulomatosis with polyangiitis.